CureDuchenne Webinar with Dyne Therapeutics | Advancing the Promise of FORCE to Deliver for Patients

  Рет қаралды 146

CureDuchenneMD

CureDuchenneMD

Күн бұрын

In this pre-recorded webinar, Dyne Therapeutics will present initial clinical data, first released on January 3rd, 2024, from the DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.

Пікірлер
Dyne Therapeutics - Meet the DM Drug Developers 2024
58:26
Myotonic Dystrophy Foundation
Рет қаралды 543
CIFFREO Data Discussion - 10 OCT 2024   EM USA DMD 0099
44:01
CureDuchenneMD
Рет қаралды 380
Это было очень близко...
00:10
Аришнев
Рет қаралды 6 МЛН
Sigma baby, you've conquered soap! 😲😮‍💨 LeoNata family #shorts
00:37
SISTER EXPOSED MY MAGIC @Whoispelagheya
00:45
MasomkaMagic
Рет қаралды 13 МЛН
KEYNOTE, Embracing OUR Future
53:06
CureDuchenneMD
Рет қаралды 461
FDA Decision on Sarepta's ELEVIDYS Webinar
49:42
CureDuchenneMD
Рет қаралды 1,9 М.
Dyne Therapeutics DELIVER trial of DYNE-251 in Duchenne
58:23
CureDuchenneMD
Рет қаралды 260
Why It Can Take Us So Long to Understand How Unwell We Are
3:25
The School of Life
Рет қаралды 4,7 М.
ADD/ADHD | What Is Attention Deficit Hyperactivity Disorder?
28:15
Understood
Рет қаралды 10 МЛН
What causes ALS?
4:14
Your ALS Guide
Рет қаралды 34 М.
Это было очень близко...
00:10
Аришнев
Рет қаралды 6 МЛН